BIOPHTA

BIOPHTA is a preclinical biotech company developing a novel technology for treating eye diseases. Their patented 'thiomer' biopolymers create an ophthalmic insert that delivers continuous drug micro-dosing for seven days, improving treatment efficacy and overcoming adherence issues associated with traditional methods. This non-invasive, self-administered therapy targets leading causes of blindness like glaucoma and macular edema.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: €6.5M

Date: 03-Jun-2024

Investors: UI Investissement, Elaia, GO Capital, Unither Pharmaceuticals, HTL Biotechnology

Markets: Biotech, Ophthalmic, Pharmaceuticals

HQ: Paris, France

Founded: 2020

Website: https://www.biophta.com/

LinkedIn: https://www.linkedin.com/company/biophta/

Twitter:

Instagram: